missing translation for 'onlineSavingsMsg'
Learn More
Learn More
Invitrogen™ Human VEGFR3 (Flt-4) Fc Chimera Recombinant Protein
Descripción
It is recommended that the protein be aliquoted for optimal storage. It is recommended that sterile water (900 μL) be added to the vial to prepare a stock solution of 1.11 mg/mL. Concentration is measured by UV.
Vascular endothelial growth factor is a key regulator of blood vessel development in embryos and angiogenesis in adult tissues. Unlike VEGF, the related VEGFC stimulates the growth of lymphatic vessels through its specificl ymphatic endothelial receptor VEGFR-3. In 1998, Dumont showed that targeted inactivation of the VEGFR-3 gene in mice resulted in defective blood vessel development in early embryos. Vasculogenesis and angiogenesis occurred, but large vessels became abnormally organized with defective lumens, leading to fluid accumulation in the pericardial cavity and cardiovascular failure at embryonic day 9.5. Thus, VEGFR3 has an essential role in the development of theembryonic cardiovascular system before the emergence of the lymphatic vessels.
Especificaciones
Especificaciones
| Número de acceso | P35916 |
| Para utilizar con (aplicación) | Control, ELISA Standard, Binding Assay |
| Formato | Lyophilized |
| Formulación | PBS with 0.01% mannitol, 5-8% trehalose, 0.01% Tween 80 and no preservative; pH 7.4 |
| ID de gen (Entrez) | 2324 |
| Peso molecular | 111.3 kDa |
| Nombre | Human VEGFR3 (Flt-4) Fc Chimera |
| Intervalo de pH | 7.4 |
| Método de purificación | Purified |
| Cantidad | 100 μg |
| Mostrar más |
Título del producto
Al hacer clic en Enviar, acepta que Fisher Scientific se ponga en contacto con usted en relación con los comentarios que ha proporcionado en este formulario. No compartiremos su información para ningún otro fin. Toda la información de contacto proporcionada se mantendrá de acuerdo con nuestra Política de Privacidad. Política de privacidad.
¿Detecta una oportunidad de mejora?